PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 112 filers reported holding PULMONX CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $484,147 | -93.1% | 46,868 | -91.3% | 0.00% | -100.0% |
| Q2 2023 | $7,050,558 | +16.1% | 537,800 | -1.0% | 0.00% | +33.3% |
| Q1 2023 | $6,072,373 | +34.3% | 543,146 | +1.3% | 0.00% | 0.0% |
| Q4 2022 | $4,520,849 | -46.2% | 536,281 | +6.3% | 0.00% | -40.0% |
| Q3 2022 | $8,404,000 | -28.7% | 504,485 | -37.0% | 0.01% | -28.6% |
| Q2 2022 | $11,779,000 | -33.0% | 800,221 | +12.9% | 0.01% | -12.5% |
| Q1 2022 | $17,588,000 | +2181.2% | 708,908 | +2851.2% | 0.01% | – |
| Q4 2021 | $771,000 | -39.8% | 24,021 | -32.5% | 0.00% | -100.0% |
| Q3 2021 | $1,280,000 | +17.1% | 35,593 | +43.6% | 0.00% | 0.0% |
| Q2 2021 | $1,093,000 | +0.7% | 24,784 | +4.5% | 0.00% | 0.0% |
| Q1 2021 | $1,085,000 | +83.0% | 23,724 | +176.2% | 0.00% | – |
| Q4 2020 | $593,000 | – | 8,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |